LifeSpan Vision Ventures is a venture capital firm focused on investing in companies developing therapeutics targeting longevity and aging reversal. Their mission is to enable healthy, strong, and vibrant human lifespans past 120 years. The firm's primary areas of interest include the whole body, joints, heart, skin, brain, and muscles. LifeSpan Vision Ventures is particularly interested in backing companies with the potential to create game-changing longevity technologies. The firm seeks to add value through its deep understanding of science and technology, the ability to lead or participate in various investment rounds (founding, seed, angel, early and mid-stage), strong financial market contacts for securing capital through various means (bank lines, follow-on equity and debt financings, and public offerings), proven entrepreneurial business ability to found and lead startups, and relationships with academics, professionals, and institutions to foster collaboration and synergy. Andrew Worden, the Founding Partner, brings decades of experience in launching, managing, planning, analyzing, and investing in public and private companies, particularly in the cleantech markets. His experience at GameChange Solar demonstrates the ability to scale businesses rapidly and successfully. Worden's background also includes experience as an investor with Barron Partners LP, where he oversaw investments in over 170 companies globally. Recent press releases highlight their commitment to investing in rejuvenation technologies. Portfolio companies being featured in the news for promising updates also supports their active involvement in the longevity biotechnology space.
Bevorzugte Reifephase für die erste Finanzierung.
longevity, aging reversal, therapeutics, whole body, joints, heart, skin, brain, muscles
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...